LON:CTEC - ConvaTec Group Share Price, Forecast & News

ConvaTec Group trades on the London Stock Exchange (LON) under the ticker symbol "CTEC."

ConvaTec Group declared a dividend on Thursday, August 1st. Stockholders of record on Thursday, September 5th will be paid a dividend of GBX 1.40 per share on Thursday, October 17th. This represents a dividend yield of 0.78%. The ex-dividend date is Thursday, September 5th. The official announcement can be seen at this link. View ConvaTec Group's Dividend History.

ConvaTec Group is scheduled to release their next quarterly earnings announcement on Friday, February 28th 2020. View Earnings Estimates for ConvaTec Group.

13 brokers have issued twelve-month price targets for ConvaTec Group's shares. Their forecasts range from GBX 113 to GBX 280. On average, they anticipate ConvaTec Group's share price to reach GBX 202.64 in the next year. This suggests a possible upside of 0.5% from the stock's current price. View Analyst Price Targets for ConvaTec Group.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last year. There are currently 3 sell ratings, 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for ConvaTec Group.

Media coverage about CTEC stock has been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. ConvaTec Group earned a daily sentiment score of 1.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for ConvaTec Group.

Some companies that are related to ConvaTec Group include Cochlear (COH), Fisher & Paykel Healthcare (FPH), Avita Medical (AVH), Stratec (SBS), Draegerwerk AG & Co KGaA (DRW3), Zynex (ZYXI), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Cyclopharm (CYC), Advanced Oncotherapy (AVO), Kromek Group (KMK), Electromed (ELMD) and Electromed (ELMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other ConvaTec Group investors own include Enquest (ENQ), Centamin (CEY), Oxford BioMedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), Afren (AFR), Genel Energy (GENL), Premier Oil (PMO), Playtech (PTEC) and Talktalk Telecom Group (TALK).

Shares of CTEC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of CTEC stock can currently be purchased for approximately GBX 201.70.

ConvaTec Group has a market capitalization of £4.00 billion and generates £1.80 billion in revenue each year. ConvaTec Group employs 9,413 workers across the globe.View Additional Information About ConvaTec Group.

The official website for ConvaTec Group is http://www.convatecgroup.com/.

ConvaTec Group's mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The company can be reached via phone at 44 11 8952 8100.